4.3 Review

Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis

E. J. Fox et al.

EUROPEAN JOURNAL OF NEUROLOGY (2012)

Article Clinical Neurology

The search for responsive clinical endpoints in primary progressive multiple sclerosis

L. V. A. E. Bosma et al.

MULTIPLE SCLEROSIS JOURNAL (2009)

Article Clinical Neurology

Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis

J. J. Kragt et al.

MULTIPLE SCLEROSIS JOURNAL (2006)

Article Clinical Neurology

Defining interferon β response status in multiple sclerosis patients

RA Rudick et al.

ANNALS OF NEUROLOGY (2004)

Article Clinical Neurology

A study validating changes in the Multiple Sclerosis Functional Composite

ELJ Hoogervorst et al.

ARCHIVES OF NEUROLOGY (2002)

Review Medicine, General & Internal

Medical progress: Multiple sclerosis.

JH Noseworthy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)